GO-CRISPR: A highly controlled workflow to discover gene essentiality in loss-of-function screens

Pirunthan Perampalam1,2,3, James I McDonald1,4, Frederick A Dick1,4,5

  • 1London Health Sciences Centre Research Institute, London Regional Cancer Program, London, ON, Canada.

Plos One
|December 18, 2024
PubMed
Summary

Guide-Only control CRISPR (GO-CRISPR) enhances loss-of-function screens for gene discovery. This improved workflow and its TRACS software robustly identify essential genes in challenging cell models like dormant ovarian cancer.